New immune therapy targets return of ovarian cancer
Disease control
Recruiting now
This early-stage trial tests a custom-made immunotherapy called Innocell for women whose ovarian cancer has returned after standard treatment. The therapy uses the patient's own tumor tissue to create a personalized vaccine-like treatment. The main goals are to check safety and s…
Phase: PHASE1 • Sponsor: PhotonPharma, Inc. • Aim: Disease control
Last updated May 14, 2026 12:04 UTC